Cargando…
The Selective HDAC6 Inhibitor ACY-738 Impacts Memory and Disease Regulation in an Animal Model of Multiple Sclerosis
Multiple sclerosis (MS) is a complex disease characterized by autoimmune demyelination and progressive neurodegeneration. Pathogenetic mechanisms of the disease remain largely unknown. Changes in synaptic functions have been reported; however, the significance of such alterations in the disease cour...
Autor principal: | LoPresti, Patrizia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6609573/ https://www.ncbi.nlm.nih.gov/pubmed/31316445 http://dx.doi.org/10.3389/fneur.2019.00519 |
Ejemplares similares
-
Silent Free Fall at Disease Onset: A Perspective on Therapeutics for Progressive Multiple Sclerosis
por: LoPresti, Patrizia
Publicado: (2018) -
HDAC6 in Diseases of Cognition and of Neurons
por: LoPresti, Patrizia
Publicado: (2020) -
Serum-Based Biomarkers in Neurodegeneration and Multiple Sclerosis
por: LoPresti, Patrizia
Publicado: (2022) -
Enhancement of pomalidomide anti-tumor response with ACY-241, a selective HDAC6 inhibitor
por: North, Brian J., et al.
Publicado: (2017) -
Pharmocologic treatment with histone deacetylase 6 inhibitor (ACY-738) recovers Alzheimer's disease phenotype in amyloid precursor protein/presenilin 1 (APP/PS1) mice
por: Majid, Tabassum, et al.
Publicado: (2015)